Algeria tightens pharmaceutical import rules with new licensing decree
Algeria has introduced stricter rules for pharmaceutical import businesses. The Ministry of the Pharmaceutical Industry issued decree No. 24 on 1 October 2025, outlining new licensing requirements. Companies now face tighter compliance checks and reporting duties to keep their licenses valid.
The new decree sets clear procedures for licensing and operating pharmaceutical import establishments. All licenses will last two years, with renewals depending on successful inspections by the National Agency for Pharmaceutical Products. Firms must also submit an annual import report by 31 January and keep detailed records of every purchase and sale.
The decree aims to standardise oversight of pharmaceutical imports in Algeria. Companies must follow the updated rules to maintain their licenses. Non-compliance risks losing the right to import medicines into the country.
